Long-term benefit of radiotherapy confirmed in advanced prostate cancer 23 Aug 2022 Radiotherapy to the prostate alongside standard treatment can keep some men with advanced prostate cancer alive for longer without detriment to quality of life, long-term study results confirm. Find out more Show/Hide
Abiraterone could halve risk of prostate cancer death for some patients 23 Dec 2021 Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading*, could halve the risk of death from the disease. Find out more Show/Hide
Abiraterone keeps men with prostate cancer at risk of spreading alive for longer 19 Sep 2021 Giving the drug abiraterone alongside standard hormone therapy helps men with high-risk prostate cancer, that has not spread elsewhere in the body, live longer. Find out more Show/Hide
Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate cancer 26 Jun 2020
ESMO 2018: Cancer trial shows treating the prostate directly with radiotherapy improves survival 22 Oct 2018